RDMA Strategy and Portfolio Associate Director

At Sobi, each person brings their unique talents to work as a team and make a difference. We are dedicated to developing and delivering innovative therapies to improve the lives of people who live with a rare disease. Our edge comes from our team of people and our commitment to patients.

Here at Sobi, our mission and culture get us excited to come to work every day, but here are a few more reasons to join our team:

• Competitive compensation for your work
• Emphasis on work/life balance
• Collaborative and team-oriented environment
• Opportunities for professional growth
• Diversity and Inclusion
• Making a positive impact to help ultra-rare disease patients who are in need of life saving treatments

Sobi is currently seeking a R&D and Medical Affairs (RDMA) Strategy and Portfolio Associate Director to join our RDMA Strategy and Operations (S&O) group. The position owns the development, execution, and continuous evolution of RDMA strategy and portfolio insights, acting as a thought partner to senior RDMA leadership. The position plays a central role in shaping portfolio‑level decisions, advancing digital and AI‑enabled capabilities, and strengthening RDMA governance and decision‑making.

Main responsibilities:

• Partner with Head of RDMA S&O to define and implement RDMA strategy
• Lead the definition and execution of the RDMA digital and AI roadmap
• Shape and continuously improve RDMA operating model, governance, and decision processes
• Translate portfolio data into clear, decision‑ready insights for RDMA LT, ExCom, and Portfolio Review Committees
• Act as RDMA strategy lead in BD scouting and due diligence, ensuring consistency, comparability, and strategic fit
• Drive preparation of high‑impact materials for senior governance forums

 

• Experience in portfolio management, R&D strategy, or enterprise‑level analytics within Pharma/Biotech
• Proven ability to synthesize complex data into executive‑level insights and recommendations
• Experience working with senior governance bodies (LT, ExCom, Portfolio Committees)
• Exposure to BD, due diligence, or asset evaluation strongly preferred
• Familiarity with R&D digital tools, portfolio systems, or analytics platforms is an advantage
• Life Science MSc or completed Medicine degree
• Professional proficiency in English
• Ability to solve complex problems, develop creative solutions, thinking dexterity
• Self-awareness, open-minded, courageous, solid ownership mindset, purpose and integrity, persist and sustain energy as well as authenticity and empathy are personal traits that will make you successful in this role

How to apply

We have an ongoing selection process in this recruitment and ask you to send your application as soon as possible. Click apply and include your resume in English. 

Why Join Us?

Here at Sobi, our mission and culture get us excited to come to work every day, but here are a few more reasons to join our team:

• Emphasis on work/life balance
• Collaborative and team-oriented environment
• Opportunities for professional growth
• Diversity and Inclusion
• Competitive compensation for your work
• Making a positive impact to help ultra-rare disease patients who are in need of life saving treatments

We are a global company with over 1,900 employees in more than 30 countries and are committed to the societies where we operate. With a deeply skilled management team directing our day-to-day wins, and a Board with a stellar track record, we’re ready to take on the world’s diseases, ailments and adversity. Our people believe they have the power to make a positive impact in others’ lives because that’s exactly what we do here. If you’re seeking a career that taps into your talents in a way that makes the world a better, healthier place, we just may have a job for you.

Sobi Culture

At Sobi, we refuse to accept the status quo. This is because we have witnessed first-hand the challenges facing those affected by rare diseases and have used this knowledge to shape our business to find new ways of helping them.

As a specialized biopharmaceutical company, we are dedicated to rare diseases. And we see this focus as a strength. By effectively turning our research into ground-breaking treatments, we help make medicine more accessible and open up more possibilities for patients and more opportunities for those caring for them. This has been our approach since day one, but we know we can’t change the world of rare diseases on our own. Accomplishing this requires strong partnerships with patients, partners and stakeholders across the entire value chain. Together, we define how our business can create solutions that serve the needs of those affected by rare diseases while facilitating sustainable growth.